Synonyms: | |
Status: | Phase 3 |
Entry Type: | Antibody |
Molecule Category: | UNKNOWN |
UNII: | MS1J9720WC |
Action | Mechanism of Action | Reference |
---|---|---|
ANTAGONIST | Hepatocyte growth factor receptor antagonist | PubMed |
Primary Target | |
---|---|
MET proto-oncogene, receptor tyrosine kinase |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Neoplasms | 3 | D009369 | ClinicalTrials |
Neoplasms | 3 | D009369 | ClinicalTrials |
Carcinoma, Non-Small-Cell Lung | 3 | D002289 | ClinicalTrials |
Stomach Neoplasms | 3 | D013274 | ClinicalTrials |
Breast Neoplasms | 2 | D001943 | ClinicalTrials |
Colorectal Neoplasms | 2 | D015179 | ClinicalTrials |
Glioblastoma | 2 | D005909 | ClinicalTrials |
Lung Neoplasms | 1 | D008175 | ClinicalTrials |
Carcinoma, Hepatocellular | 1 | D006528 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 1133766-06-9 |
ChEMBL | CHEMBL1743051 |
FDA SRS | MS1J9720WC |
Guide to Pharmacology | 8966 |